• Sodium phosphate dibasic (B7293): Reliable Buffering for Cel

  2026-04-27

  This article delivers actionable, scenario-driven guidance on using Sodium phosphate dibasic (SKU B7293) as a high-purity, water-soluble buffer for cell viability, proliferation, and aquatic toxicity assays. Integrating peer-reviewed data and real-world workflow challenges, we demonstrate how Na2HPO4 ensures reproducible pH control and assay integrity for biomedical researchers and technicians.

• BET Bromodomain Inhibitor, (+)-JQ1: Applied Workflows & Opti

  2026-04-27

  Bromodomain Inhibitor, (+)-JQ1 empowers translational researchers with precision control over BET bromodomain signaling, enabling robust apoptosis assays, inflammation modulation, and innovative male contraception studies. This guide translates cutting-edge findings and workflow enhancements into actionable protocols for reliable, reproducible results.

• MPC-Mediated Lactate Regulates Histone Lactylation and Tumor

  2026-04-26

  This study reveals that downregulation of mitochondrial pyruvate carrier (MPC) in colorectal cancer enhances lactate production, which in turn elevates histone lactylation in dendritic cells and impairs anti-tumor immunity. The findings highlight the metabolic-epigenetic interplay shaping tumor progression and suggest new avenues for improving immunotherapy via modulation of lactate metabolism.

• A23187, Free Acid: Decoding Cellular Calcium Dynamics in Can

  2026-04-25

  Explore how A23187, free acid—a potent calcium ionophore—enables nuanced interrogation of intracellular calcium signaling in cancer research. This article uniquely bridges advanced mechanistic insight, protocol optimization, and critical evaluation of assay strategies.

• Tolazoline in Precision Endocrine & Airway Research: Beyond

  2026-04-24

  Explore how Tolazoline, a leading α2-adrenergic receptor antagonist, enables advanced endocrine and airway research through dual-pathway modulation. This article uniquely bridges mechanistic depth with practical assay optimization and reference-driven insights.

• Pravastatin Sodium: Applied Protocols for Cholesterol & Beyo

  2026-04-24

  Pravastatin sodium, a potent HMG-CoA reductase inhibitor, enables precise modulation of cholesterol biosynthesis across diverse in vitro and in vivo models. This guide delivers stepwise experimental strategies, troubleshooting insights, and workflow enhancements leveraging APExBIO's trusted quality for robust cardiovascular and translational research.

• Crystal Violet Staining Solution: Quantitative Biofilm Insig

  2026-04-23

  Explore the scientific principles and quantitative applications of Crystal Violet Staining Solution as a nuclear staining dye in biofilm and cell-based assays. This article reveals unique assay design strategies, drawing on recent breakthroughs to optimize research outcomes.

• Taraxasterol Attenuates Osteoporosis via Necroptosis Suppres

  2026-04-23

  This study demonstrates that taraxasterol, a triterpenoid from Taraxacum officinale, alleviates osteoporosis by targeting the PI3K/AKT/PPARγ pathway to suppress necroptosis and restore the balance between osteogenic and adipogenic differentiation in bone marrow mesenchymal stem cells (BMSCs). The findings clarify a mechanistic link between necroptosis and bone-fat imbalance, suggesting new molecular targets for osteoporosis intervention.

• Platanoside Mitigates Ferroptosis in ALI via Keap1-Nrf2-GPX4

  2026-04-22

  This study elucidates how platanoside protects against acute lung injury (ALI) by promoting autophagy-dependent Keap1 degradation, thereby activating the Nrf2/GPX4 antioxidant pathway and suppressing ferroptosis. The findings highlight a promising therapeutic mechanism targeting redox balance and cellular integrity in inflammatory lung pathology.

• Adefovir (GS-0393): Applied Workflows in HBV Antiviral Resea

  2026-04-22

  Adefovir (GS-0393) stands out as a gold-standard HBV DNA polymerase inhibitor and renal transporter probe, enabling precise, reproducible workflows for hepatitis B virus research. This article translates its mechanistic strengths into optimized experimental protocols, advanced applications, and practical troubleshooting tips for high-impact virology and pharmacokinetics studies.

• High-Throughput Blood-Brain Barrier Modeling with LLC-PK1-MD

  2026-04-21

  This study introduces an in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK and MDR1 cell lines, enabling high-throughput prediction of CNS drug permeability. The approach integrates lysosomal trapping correction and demonstrates strong concordance with in vivo brain distribution, streamlining early-stage neurological drug screening.

• CX-5461 Induces DNA Damage and Mitotic Catastrophe in Cervic

  2026-04-21

  This study demonstrates that CX-5461, a selective RNA polymerase I inhibitor, impairs cervical cancer cell growth by inducing DNA damage and mitotic catastrophe, and enhances cisplatin sensitivity. The findings provide a mechanistic rationale for targeting Pol I-driven ribosome biogenesis as a therapeutic strategy in both primary and platinum-resistant cervical cancer.

• Modeling HSV-1 Latency in Human iPSC-Derived Sensory Neurons

  2026-04-20

  This study presents a scalable protocol for differentiating human inducible pluripotent stem cells (hiPSCs) into functional sensory neurons, which support latent infection and reactivation of herpes simplex virus 1 (HSV-1). By validating latency-associated viral gene expression and chromatin changes, this system advances mechanistic investigations of HSV-1 in human neuronal contexts, overcoming translational limitations of animal models.

• Translational Immunodetection: Amplifying Impact with HyperF

  2026-04-20

  Explore how the HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody integrates advanced fluorescence detection with strategic assay enhancement, empowering translational researchers to achieve exceptional sensitivity and reliability across immunofluorescence, Western blotting, and flow cytometry. Drawing from mechanistic insights, peer-reviewed vaccine research, and protocol benchmarks, this thought-leadership article from APExBIO bridges the gap between technical rigor and translational impact—moving beyond standard product narratives to provide actionable guidance for the next generation of immunodetection.

• PCI-32765 (Ibrutinib): Workflow Optimization in B-Cell and G

  2026-04-19

  PCI-32765 (Ibrutinib) transforms B-cell and ATRX-deficient glioma research with its potent, selective BTK inhibition and robust support for cell viability, signaling, and combinatorial assay designs. This guide delivers actionable, evidence-backed workflows, troubleshooting strategies, and cross-model protocol enhancements, enabling researchers to maximize reproducibility and experimental insight with APExBIO’s gold-standard inhibitor.

11483 records 1/766 page Next 12345 下5页 Last page